Freedom Day Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.54M | Sell |
5,714
-127
| -2% | -$56.5K | 0.76% | 47 |
|
|
2025
Q1 | $2.83M | Sell |
5,841
-58
| -1% | -$28.1K | 0.87% | 32 |
|
|
2024
Q4 | $2.38M | Sell |
5,899
-10
| -0.2% | -$4.03K | 0.71% | 42 |
|
|
2024
Q3 | $2.75M | Buy |
5,909
+18
| +0.3% | +$8.37K | 0.85% | 32 |
|
|
2024
Q2 | $2.76M | Buy |
5,891
+237
| +4% | +$111K | 0.93% | 26 |
|
|
2024
Q1 | $2.36M | Sell |
5,654
-54
| -0.9% | -$22.6K | 0.84% | 35 |
|
|
2023
Q4 | $2.32M | Buy |
5,708
+986
| +21% | +$401K | 0.91% | 30 |
|
|
2023
Q3 | $1.64M | Buy |
4,722
+115
| +2% | +$40K | 0.72% | 47 |
|
|
2023
Q2 | $1.62M | Buy |
4,607
+176
| +4% | +$61.9K | 0.72% | 51 |
|
|
2023
Q1 | $1.4M | Buy |
4,431
+629
| +17% | +$198K | 0.66% | 59 |
|
|
2022
Q4 | $1.1M | Buy |
+3,802
| New | +$1.1M | 0.55% | 64 |
|
|
2021
Q2 | – | Sell |
-1,707
| Closed | -$367K | – | 121 |
|
|
2021
Q1 | $367K | Buy |
1,707
+258
| +18% | +$55.5K | 0.2% | 87 |
|
|
2020
Q4 | $342K | Sell |
1,449
-2,880
| -67% | -$680K | 0.19% | 85 |
|
|
2020
Q3 | $1.17M | Sell |
4,329
-103
| -2% | -$27.7K | 0.69% | 62 |
|
|
2020
Q2 | $1.29M | Buy |
+4,432
| New | +$1.29M | 0.85% | 60 |
|